Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

ClinicalTrials.gov ID: NCT06966453

Public ClinicalTrials.gov record NCT06966453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 5, 2026, 1:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 1B/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to treat and has spread in the body (advanced cancer). This study is seeking participants who: * have breast cancer that is hard to treat and has spread in the body (advanced cancer) * have tumors that have HER2 on them * have received previous treatment for their advanced breast cancer All participants in this study will receive disitamab vedotin at the study clinic once every 2 weeks as an intravenous (IV) infusion (given directly into a vein). Participants will take the study medicine until they or their doctor decides to stop. This might be because their cancer is getting worse, the study medicine is no longer helping, they have bad side effects, or they wish to stop taking the study medicine. During this time, the participants will have study visits every 2 weeks. After the participants have stopped taking the study medicine, they will have follow-up visits about every 6 weeks unless their cancer gets worse. After that, they will have follow-up phone calls about every 12 weeks. The study team will look at the experiences of people receiving the study medicine. This will help the study team decide if the study medicine is safe and effective.

Study identification

NCT ID
NCT06966453
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
74 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2025 (Actual)
Primary completion
Oct 25, 2027 (Estimated)
Completion
Jan 27, 2030 (Estimated)
Last update posted
Sep 9, 2026

2025 – 2030

United States locations

U.S. sites
136
U.S. states
14
U.S. cities
110
Facility City State ZIP Site status
Southern Cancer Center, PC Daphne Alabama 36526 —
Southern Cancer Center, PC Foley Alabama 36535 —
Southern Cancer Center, PC Mobile Alabama 36608 —
Banner Gateway Medical Center Gilbert Arizona 85234 —
Banner MD Anderson Cancer Center Gilbert Arizona 85234 —
Oncura Health - Anaheim Anaheim California 92805 —
City of Hope National Medical Center Duarte California 91010 —
Stanford Cancer Center Emeryville Emeryville California 94608 —
Oncura Health - Fountain Valley Fountain Valley California 92708 —
Oncura Health - Corporate Glendale California 91204 —
City of Hope at Irvine Lennar Irvine California 92618 —
Oncura Health - Good Samaritan Los Angeles California 90017 —
Valkyrie Clinical Trials Los Angeles California 90067 —
Mission Community Hospital (Satellite Site) Los Angeles California 91402 —
Clinical and Translational Research Unit (CTRU) Palo Alto California 94304 —
Stanford Cancer Center Palo Alto California 94304 —
Stanford Women's Cancer Center Palo Alto California 94304 —
Stanford Cancer Center Pleasanton Pleasanton California 94588 —
Stanford Healthcare - Portola Valley Portola California 94208 —
Stanford University Cancer Center South Bay San Jose California 95124 —
Stanford Health Care, Investigational Drug Service Stanford California 94305 —
Oncura Health -Valley Presbyterian Van Nuys California 91405 —
Rocky Mountain Cancer Centers, LLP Aurora Colorado 80012 —
Rocky Mountain Cancer Centers, LLP Boulder Colorado 80303 —
Rocky Mountain Cancer Centers, LLP Centennial Colorado 80112 —
Rocky Mountain Cancer Centers, LLP Colorado Springs Colorado 80907 —
Rocky Mountain Cancer Centers, LLP Colorado Springs Colorado 80923 —
Rocky Mountain Cancer Centers, LLP Denver Colorado 80220 —
Rocky Mountain Cancer Centers, LLP Englewood Colorado 80113 —
Rocky Mountain Cancer Centers, LLP Lakewood Colorado 80228 —
Rocky Mountain Cancer Centers, LLP Littleton Colorado 80120 —
Rocky Mountain Cancer Centers, LLP Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers, LLP Longmont Colorado 80504 —
Rocky Mountain Cancer Centers, LLP Pueblo Colorado 81003 —
Rocky Mountain Cancer Centers, LLP Thornton Colorado 80260 —
Smilow Cancer Hospital - Derby Derby Connecticut 06418 —
Smilow Cancer Hospital - Fairfield Fairfield Connecticut 06824 —
Smilow Cancer Hospital - Glastonbury Glastonbury Connecticut 06033 —
Smilow Cancer Hospital - Greenwich Greenwich Connecticut 06830 —
Smilow Cancer Hospital - Guilford Guilford Connecticut 06437 —
Smilow Cancer Hospital at St. Francis Hartford Connecticut 06105 —
Smilow Cancer Hospital - Yale New Haven Health New Haven Connecticut 06510 —
Yale-New Haven Hospital New Haven Connecticut 06510 —
Yale University - Smilow Cancer Hospital; C/O Thomas Ferencz, RPh, BCOP New Haven Connecticut 06511 —
Yale School of Medicine New Haven Connecticut 06520 —
Smilow Cancer Hospital - North Haven North Haven Connecticut 06473 —
Smilow Cancer Hospital - Long Ridge Stamford Connecticut 06902 —
Smilow Cancer Hospital - Torrington Torrington Connecticut 06790 —
Smilow Cancer Hospital - Trumbull Trumbull Connecticut 06611 —
Smilow Cancer Hospital - Waterbury Waterbury Connecticut 06708 —
Smilow Cancer Hospital - Waterford Waterford Connecticut 06385 —
Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy Washington D.C. District of Columbia 20007 —
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Florida Cancer Specialists Clearwater Florida 33761 —
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center Coral Gables Florida 33146 —
Sylvester Comprehensive Cancer Center - Coral Springs Coral Springs Florida 33065 —
University of Miami Hospital and Clinics - Deerfield Beach Deerfield Beach Florida 33442 —
Sylvester Comprehensive Cancer Center- Doral Doral Florida 33166 —
Florida Cancer Specialists Gainesville Florida 32605 —
Sylvester Comprehensive Cancer Center - Hollywood Hollywood Florida 33021 —
Florida Cancer Specialists Largo Florida 33770 —
Florida Cancer Specialists Lecanto Florida 34461 —
Sylvester Comprehensive Cancer Center Miami Florida 33136 —
University of Miami Hospital and Clinics Miami Florida 33136 —
Sylvester Comprehensive Cancer Center - Kendall Miami Florida 33176 —
Sylvester Comprehensive Cancer Center - Sole Mia North Miami Florida 33181 —
Florida Cancer Specialists Ocala Florida 34474 —
Florida Cancer Specialists Orange City Florida 32763 —
Florida Cancer Specialists Orlando Florida 32806 —
Sylvester Comprehensive Cancer Center - Plantation Plantation Florida 33324 —
Florida Cancer Specialists St. Petersburg Florida 33701 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Florida Cancer Specialists Tallahassee Florida 32308 —
Florida Cancer Specialists Tampa Florida 33607 —
Florida Cancer Specialists Tavares Florida 32778 —
Florida Cancer Specialists The Villages Florida 32159 —
Florida Cancer Specialists Trinity Florida 34655 —
Florida Cancer Specialists Winter Park Florida 32789 —
Winship Cancer Institute @ Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory Clinic Investigational Drug Services Atlanta Georgia 30322 —
Emory University Hospital Atlanta Georgia 30322 —
Winship Cancer Institute Atlanta Georgia 30322 —
Oncology Associates of Oregon, P.C. Albany Oregon 97321 —
Oncology Associates of Oregon, P.C. Eugene Oregon 97401 —
Oncology Associates of Oregon, P.C. Springfield Oregon 97477 —
Alliance Cancer Specialists, PC Bensalem Pennsylvania 19020 —
Alliance Cancer Specialists, PC Doylestown Pennsylvania 18901 —
Alliance Cancer Specialists, PC Horsham Pennsylvania 19044 —
Alliance Cancer Specialists, PC Langhorne Pennsylvania 19047 —
Alliance Cancer Specialists, PC Media Pennsylvania 19063 —
Alliance Cancer Specialists, PC Sellersville Pennsylvania 18960 —
Alliance Cancer Specialists, PC Wynnewood Pennsylvania 19096 —
Sarah Cannon Research Institute - Pharmacy Nashville Tennessee 37203 —
SCRI Oncology Partners Nashville Tennessee 37203 —
Texas Oncology-Northeast Texas Allen Texas 75013 —
Texas Oncology - DFW Arlington Texas 76012 —
Texas Oncology - DFW Arlington Texas 76014 —
Texas Oncology - DFW Bedford Texas 76022 —
Texas Oncology - DFW Dallas Texas 75203 —
Texas Oncology - DFW Dallas Texas 75230 —
Texas Oncology - DFW Dallas Texas 75231 —
Texas Oncology - DFW Dallas Texas 75237 —
Texas Oncology - DFW Dallas Texas 75246 —
Texas Oncology-Northeast Texas Denison Texas 75020 —
Texas Oncology-Northeast Texas Denton Texas 76201 —
Texas Oncology-Northeast Texas Flower Mound Texas 75028 —
Texas Oncology - DFW Fort Worth Texas 76104 —
Texas Oncology - DFW Grapevine Texas 76051 —
US Oncology Investigation Products Center(IPC) Irving Texas 75063 —
US Oncology Investigational Product Center (IPC) Irving Texas 75063 —
Texas Oncology-Northeast Texas Lewisville Texas 75056 —
Texas Oncology-Northeast Texas Longview Texas 75601 —
Texas Oncology-Northeast Texas McKinney Texas 75071 —
Texas Oncology-Northeast Texas Palestine Texas 75801 —
Texas Oncology-Northeast Texas Paris Texas 75460 —
Texas Oncology - DFW Plano Texas 75075 —
Texas Oncology - DFW Plano Texas 75093 —
Texas Oncology - San Antonio San Antonio Texas 78217 —
Texas Oncology - San Antonio San Antonio Texas 78240 —
Texas Oncology-Northeast Texas Tyler Texas 75702 —
Virginia Cancer Specialists, PC Arlington Virginia 22201 —
Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care Blacksburg Virginia 24060 —
Virginia Oncology Associates Chesapeake Virginia 23320 —
Virginia Cancer Specialists, PC Fairfax Virginia 22031 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Low Moor Virginia 24457 —
Virginia Cancer Specialists, PC Manassas Virginia 20110 —
Virginia Oncology Associates Newport News Virginia 23606 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Cancer Specialists, PC Reston Virginia 20190 —
Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care Roanoke Virginia 24014 —
Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care Salem Virginia 24153 —
Virginia Oncology Associates Virginia Beach Virginia 23456 —
Virginia Oncology Associates Williamsburg Virginia 23188 —
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Wytheville Virginia 24382 —
Swedish Cancer Institute Seattle Washington 98104 —
Swedish Medical Center Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06966453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Oct 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06966453 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →